Dyadic International, Inc. is a biotechnology company based in Florida that creates and sells enzymes and proteins used in the development of vaccines and drugs for humans and animals. They utilize their C1 platform and other proprietary technologies to conduct research and commercial activities for their products. The company has research agreements with VTT Technical Research Centre in Finland and a strategic research services agreement with Biotechnology Developments for Industry in Pharmaceuticals.